2025
SJR Q2
JCR Q2 · 2,9
131 matched articles
SCIE
Journal detail
Pharmaceutical Development and Technology
- Publisher
- Taylor and Francis Ltd.
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
1083745010979867
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,471
- Quartile Q2
- H-Index 79
- Cites/doc 2,95
- Docs (3y) 288
- Cites (3y) 917
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,9
- 5Y JIF 3,2
- JCI 0,75
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q3
- Pharmaceutical Science Q2
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,471 | 2,9 | 3,2 | 0,75 | Q2 | 79 |
| 2024 | Q2 | Q3 | 0,463 | 2,5 | 2,8 | 0,72 | Q2 | 74 |
| 2023 | Q2 | Q2 | 0,476 | 2,6 | 3,1 | 0,83 | Q2 | 74 |
| 2022 | Q2 | Q2 | 0,481 | 3,4 | 3,2 | 0,96 | Q2 | 74 |
| 2021 | Q2 | Q2 | 0,511 | 3,9 | 3,3 | 0,92 | Q2 | 74 |
| 2020 | Q2 | Q3 | 0,511 | 3,1 | 2,9 | 1,01 | Q2 | 74 |
| 2019 | Q2 | Q3 | 0,441 | 2,2 | 1,9 | 0,83 | Q2 | 74 |
| 2018 | — | Q3 | — | 2,3 | 2,1 | 0,8 | Q2 | — |
| 2017 | Q2 | Q3 | 0,479 | 1,9 | 1,8 | 0,67 | Q3 | 74 |
| 2016 | Q2 | Q3 | 0,531 | 1,9 | 1,6 | — | — | 74 |
| 2015 | Q2 | Q3 | 0,489 | 1,6 | 1,4 | — | — | 74 |
| 2014 | Q2 | Q4 | 0,509 | 1,2 | 1,2 | — | — | 74 |
| 2013 | Q2 | Q3 | 0,452 | 1,3 | 1,3 | — | — | 74 |
| 2012 | Q2 | Q3 | 0,582 | 1,3 | 1,2 | — | — | 74 |
| 2011 | Q2 | Q3 | 0,485 | 1,4 | 1,4 | — | — | 74 |
| 2010 | Q1 | Q4 | 0,612 | 1,1 | 1,4 | — | — | 74 |
| 2009 | — | Q4 | — | 0,9 | 1,1 | — | — | — |
| 2008 | — | Q4 | — | 1 | 1,2 | — | — | — |
| 2007 | — | Q4 | — | 0,9 | 1,1 | — | — | — |
| 2006 | — | Q4 | — | 0,7 | — | — | — | — |
| 2005 | — | Q4 | — | 0,8 | — | — | — | — |
| 2004 | — | Q4 | — | 0,6 | — | — | — | — |
| 2003 | — | Q4 | — | 0,7 | — | — | — | — |
| 2002 | — | Q4 | — | 0,6 | — | — | — | — |
| 2001 | — | Q4 | — | 0,8 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 173/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 181/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 173/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 125/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 119/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 156/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 184/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 153/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 177/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 175/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 188/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 206/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 185/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 188/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 191/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 196/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 196/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 182/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 172/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 178/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 163/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 163/187 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 155/185 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 154/188 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 140/186 |